Amynas
Wouwstraat 96
2540 Hove
BE
Amynas
Foundation date
23/12/2019
Sector
#Medical TechnologySubsector
Amynas’ lead candidate product is a bio-envelope made of electrospun nanofibers designed to promote healthy tissue growth around the implant (anti-inflammatory and anti-scarring) and reduce the infection rate, resulting in fewer re-admission rates for post-surgical complications.
Upcoming events
All events-
2809 '22
NLSDays 2022
Event by: SwedenBIO -
2809 '22
Neurotechnologies
Event by: VIB -
0712 '22
Emerging Applications of Microbes (2nd edition)
Event by: VIB
Latest news
More news-
ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder
19 hours ago
Read more
-
Confo Therapeutics awarded EUR 1.7M VLAIO grant to expand application of ConfoBody® drug discovery and development technology in rare diseases
Tuesday June 28th 2022
Read more
-
MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis
Tuesday June 28th 2022
Read more
Jobs
More jobs-
05/07/22
Brussels
Postdoctoral position in cancer immunology and the tumor immune microenvironment
Permanent
VIB -
-
05/07/22
Brussels, East Flanders, Flemish Brabant
Benelux HR Specialist
Temporary
Agilent Technologies